Impact of imaging biomarkers from body composition analysis on outcome of endovascularly treated acute ischemic stroke patients
Acute ischemic stroke patients with a lower sarcopenia marker are at risk for an unfavorable outcome. Imaging biomarkers extracted from BCA can be easily obtained from existing CT images, making it readily available at the beginning of treatment. However, further research is necessary to determine whether sarcopenia provides additional value beyond established outcome predictors. Understanding its role could lead to optimized, individualized treatment plans for post-stroke patients, potentially improving recovery outcomes.
Authors
- Luca Salhöfer (ORCID: https://orcid.org/0000-0002-5376-3154)
- René Hosch (ORCID: https://orcid.org/0000-0003-1760-2342)
- Christian Rubbert (ORCID: https://orcid.org/0000-0002-9461-1173)
- Johannes Haubold (ORCID: https://orcid.org/0000-0003-4843-5911)
- Nikolas Beck (ORCID: https://orcid.org/0000-0002-5987-2351)
- Cornelius Deuschl (ORCID: https://orcid.org/0000-0001-9262-7289)
- Lukas Goertz
- Hanna Styczen (ORCID: https://orcid.org/0000-0002-9623-4156)
- Volker Maus (ORCID: https://orcid.org/0000-0001-5097-2631)
- Felix Nensa (ORCID: https://orcid.org/0000-0002-5811-7100)
- Mathias Holtkamp
- R. Schubert
- Daniel J. Weiss
Institutions
- Klinikum Aschaffenburg (DE)
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Essen University Hospital (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Journal of NeuroInterventional Surgery
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1136/jnis-2024-022275
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.39